Marimar Otero-Rojas
Adult Health · Salt Lake City, UTNPI 1699347732
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Amgen at 25.4% of the total.
Across 31 payments — averaging $28.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$226
- AstraZeneca$205
- Fresenius USA Marketing, Inc.$138
- Otsuka America Pharmaceutical, Inc.$79
- Travere Therapeutics, Inc.$76
- Vifor Pharma, Inc.$42
- plus $123 from 5 others
What the payments were for
- Food & beverage$891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 6 | $226 |
| AstraZeneca(2 entities) | 8 | $205 |
| Fresenius USA Marketing, Inc. | 2 | $138 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Travere Therapeutics, Inc. | 3 | $76 |
| Vifor Pharma, Inc. | 2 | $42 |
| Baxter Healthcare | 1 | $39 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| Calliditas Therapeutics US Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$891 in reported general payments places this provider in the 70th percentile of 53 adult health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 28 | $17,930 |
| Sevelamer Carbonate | 21 | $5,967 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,272 |
| Gabapentin | 78 | $1,412 |
| Calcium Acetate | 21 | $1,298 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $1,087 |
| Duloxetine Hcl | 31 | $1,019 |
| Trazodone Hcl | 75 | $963 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $837 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $693 |
| Oxycodone Hcl | 13 | $679 |
| Atorvastatin Calcium | 50 | $655 |
| Bupropion Hcl SrBupropion Hcl | 15 | $608 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $570 |
Paid to pharmacies, not to this prescriber.
Other adult health in Salt Lake City
- Kristin LarsonSalt Lake City$75K
- Lucinda RossSalt Lake City$4K
- Joanne NamSalt Lake City$3K
- Irene CheongSalt Lake City$2K
- Rachel StraightSalt Lake City$1K
- Elizabeth CardenasSalt Lake City$851
- Bennett NavarroSalt Lake City$656
- Laura CannonSalt Lake City$464
- Karen FronkSalt Lake City$396
- Cristine TuttleSalt Lake City$333
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.